期刊文献+

卵巢透明细胞癌21例临床病理分析 被引量:1

暂未订购
导出
摘要 目的:探讨卵巢透明细胞癌的临床及病理特点。方法:回顾性分析21例卵巢透明细胞癌患者的临床、病理特点、治疗和预后情况。结果:术中发现有腹水且多脏器浸润。病理表现特征性的透明细胞和鞋钉细胞。免疫组化CK(+)14例,leu M1(+)5例,甲胎蛋白(+)2例,Vimentin均阴性。Ⅰ~Ⅱ期7例,2年及5年生存率为85.7%及57.1%,Ⅲ~Ⅳ期14例,2年及5年生存率则为57.1%及28.6%(P<0.05),总的5年生存率为38.1%。结论:卵巢透明细胞癌预后不良,手术和化疗为主要治疗方式,放疗可以延长生存期。Ⅲ~Ⅳ期患者较Ⅰ~Ⅱ期预后更差。
作者 袁昌玉
出处 《医学理论与实践》 2012年第4期438-439,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献7

二级参考文献30

  • 1骆福添,中国卫生统计,1987年,4卷,59页
  • 2林巧稚,妇科肿瘤,1982年
  • 3宋鸿钊,中华妇产科杂志,1955年,1卷,1页
  • 4石一复,实用肿瘤杂志,1988年,3期,24页
  • 5陈其芳,中华妇产科杂志,1985年,20卷,76页
  • 6范--娣,实用卵巢肿瘤学,1984年
  • 7Zang R Y,J Exp Clin Cancer Res,1999年,18卷,449页
  • 8Eisenkop S M,Gynecol Oncol,1998年,69卷,103页
  • 9Boente M P,Semin Oncol,1998年,25卷,326页
  • 10Shimizu Y,Umezawa S,Hasumi K,et al.A phase Ⅱ study of combined CPT-11 and mitomycin-C in platinum refractory clear cell and mucinous ovarian carcinoma.Ann Acad Med Singapore,1998,27(5):650-656

共引文献60

同被引文献13

  • 1Tan DS,Miller RE,Kaye SB.New perspectives on molecular targeted therapy in ovarian clear cell carcinoma[J].Br J Cancer,2013,108 (8):1553-1559.
  • 2Yamashita Y,Akatsuka S,Shinjo K,et al.Met is the most frequently amplified gene in endometriosis-associated ovarian clear cell adenocarcinoma and correlates with worsened prognosis[J].PLoS One,2013,8 (3):e57724-57734.
  • 3Rauh-Hain JA,Davis M,Clemmer J,et al.Prognostic determinants in patients with uterine and ovarian clear cell carcinoma:a SEER analysis[J].Gynecol Oncol,2013,131 (2):404-409.
  • 4Min KW,Park MH,Hong SR,et al.Clear cell carcinomas of the ovary:a multi-institutional study of 129 cases in Korea with prognostic significance of Emi1 and Galectin-3[J].Int J Gynecol Patho1,2013,32(1):3-14.
  • 5Skirnisdottir I,Bjersand K,Akerud H,et al.Napsin A as a marker of clear cell ovarian carcinoma[J].BMC Cancer,2013,13:524-535.
  • 6Machida S,Sato T,Fujiwara H,et al.Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma[J].Oncol Lett,2012,4(5):1017-1022.
  • 7Offman SL,Longacre TA.Clear cell carcinoma of the female genital tract (not everything is as clear as it seems)[J].Adv Anat Pathol,2012,19 (5):296-312.
  • 8Samartzis EP,Noske A,Dedes KJ,et al.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas[J].Int J Mol Sci,2013,14(9):18824-18849.
  • 9Lim SH,Kim YH,Yim GW,et al.Primary omental yolk sac tumor[J].Obstet Gynecol Sci,2013,56(6):412-415.
  • 10Bai S,Wei S,Ziober A,et al.SALL4 and SF-1 are sensitive and specific markers for distinguishing granulosa cell tumors from yolk sac tumors[J].Int J Surg Pathol,2013,21 (2):121-125.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部